Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Champ Resto Indonesia Tbk. (ENAK) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Champ Resto Indonesia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Champ Resto Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Champ Resto Indonesia Tbk. trades at Rp224 (market cap 494B, 437.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Champ Resto Indonesia Tbk. is far larger — about 3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Champ Resto Indonesia Tbk. is more actively traded (437.2K versus 324K). Which is the better fit depends on your goals.

ENAKOBAT
Market Cap
494B166.01B
Volume
437.2K324K
Lot
4.37K3.24K
Turnover
97.63M77.68M
Average Price
223.3239.75
Value
97.63M77.68M
Indicative Equilibrium Price
224240
Indicative Equilibrium Volume
101

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ENAK
View details
OBAT
View details

About Champ Resto Indonesia Tbk.

PT Champ Resto Indonesia Tbk ("Company") was established based on the Notarial Deed of Catherina Situmorang, S.H., No. 20 dated March 22, 2010.

Read more on ENAK

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT